These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22927692)

  • 1. A review of Friedreich ataxia clinical trial results.
    Perlman SL
    J Child Neurol; 2012 Sep; 27(9):1217-22. PubMed ID: 22927692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.
    Nachbauer W; Wanschitz J; Steinkellner H; Eigentler A; Sturm B; Hufler K; Scheiber-Mojdehkar B; Poewe W; Reindl M; Boesch S
    Mov Disord; 2011 Aug; 26(10):1935-8. PubMed ID: 21692115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the gene in Friedreich ataxia.
    Hebert MD
    Biochimie; 2008 Aug; 90(8):1131-9. PubMed ID: 18206656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.
    Lynch DR; Farmer JM; Balcer LJ; Wilson RB
    Arch Neurol; 2002 May; 59(5):743-7. PubMed ID: 12020255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.
    Babady NE; Carelle N; Wells RD; Rouault TA; Hirano M; Lynch DR; Delatycki MB; Wilson RB; Isaya G; Puccio H
    Mol Genet Metab; 2007; 92(1-2):23-35. PubMed ID: 17596984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C; Fancellu R; Caldarazzo S; Nanetti L; Di Bella D; Plumari M; Lauria G; Cappellini MD; Duca L; Solari A; Taroni F
    Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and therapy for cardiomyopathy in Friedreich's ataxia.
    Lynch DR; Regner SR; Schadt KA; Friedman LS; Lin KY; St John Sutton MG
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):767-77. PubMed ID: 22894632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
    Sarsero JP; Li L; Wardan H; Sitte K; Williamson R; Ioannou PA
    J Gene Med; 2003 Jan; 5(1):72-81. PubMed ID: 12516053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.
    Ashley CN; Hoang KD; Lynch DR; Perlman SL; Maria BL
    J Child Neurol; 2012 Sep; 27(9):1095-120. PubMed ID: 22859693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in children with Friedreich ataxia.
    Paulsen EK; Friedman LS; Myers LM; Lynch DR
    Pediatr Neurol; 2010 May; 42(5):335-7. PubMed ID: 20399387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in Neurological Therapeutics for Friedreich Ataxia and Machado-Joseph Disease].
    Yabe I; Sasaki H
    Brain Nerve; 2017 Aug; 69(8):913-924. PubMed ID: 28819075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the progression of Friedreich ataxia and its treatment.
    Delatycki MB
    J Neurol; 2009 Mar; 256 Suppl 1():36-41. PubMed ID: 19283349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 150 years of Friedreich ataxia: from its discovery to therapy.
    Schulz JB; Pandolfo M
    J Neurochem; 2013 Aug; 126 Suppl 1():1-3. PubMed ID: 24024236
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
    Schmucker S; Puccio H
    Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Friedreich ataxia--diagnosis after a decade. Differential diagnosis of inherited spinocerebellar ataxias].
    Vitaszil E; Jelencsik I; Szirmai I
    Ideggyogy Sz; 2002 Nov; 55(11-12):382-93. PubMed ID: 12632799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ for Friedreich ataxia: present evidence.
    Wells M; Seyer L; Schadt K; Lynch DR
    Neurodegener Dis Manag; 2015 Dec; 5(6):497-504. PubMed ID: 26634868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common data elements for clinical research in Friedreich's ataxia.
    Lynch DR; Pandolfo M; Schulz JB; Perlman S; Delatycki MB; Payne RM; Shaddy R; Fischbeck KH; Farmer J; Kantor P; Raman SV; Hunegs L; Odenkirchen J; Miller K; Kaufmann P
    Mov Disord; 2013 Feb; 28(2):190-5. PubMed ID: 23239403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and progression of Friedreich ataxia and implications for physical therapist examination.
    Maring JR; Croarkin E
    Phys Ther; 2007 Dec; 87(12):1687-96. PubMed ID: 17911272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Friedreich's ataxia: recent developments and prospects for treatment].
    Legros B; Manto MU
    Rev Med Brux; 1999 Apr; 20(2):73-9. PubMed ID: 10335100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncommon features in Cuban families affected with Friedreich ataxia.
    Cruz-Mariño T; González-Zaldivar Y; Laffita-Mesa JM; Almaguer-Mederos L; Aguilera-Rodríguez R; Almaguer-Gotay D; Rodríguez-Labrada R; Canales-Ochoa N; Macleod P; Velázquez-Pérez L
    Neurosci Lett; 2010 Mar; 472(2):85-9. PubMed ID: 20109528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.